Innodal was launched in 2017, to produce bacteriocins and other natural antimicrobials for food processing. In 2020, Innodal’s flagship product, Inneo, was the first bacteriocin recognized by Health Canada as a processing aid, and the technology recently received the same approval by the FDA/USDA in 2024. Inneo is an antimicrobial composed of Pediocin that mitigates Listeria risks. Inneo demonstrates strong activity against the pathogenic strains Listeria monocytogenes and Clostridium perfringens with minimum inhibitory concentrations (MIC) of 6.8 nM and 37.8 nM, respectively. Inneo is clean label and a thousand times more effective than traditional methods, and available in dry and liquid formats. This processing aid does not require labeling, thus there is no need to modify packaging labels and is the most efficient solution to protect consumers against Listeria and your company against recalls.